arginyl-glycyl-aspartic acid has been researched along with gemcitabine in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 3 (37.50) | 2.80 |
| Authors | Studies |
|---|---|
| Davis, JJ; Fang, B; Jacob, D; Teraishi, F; Zhang, L; Zhu, H | 1 |
| Akashi, Y; Enomoto, T; Hashimoto, S; Kurokawa, T; Miyamoto, R; Oda, T; Ohara, Y; Ohkohchi, N; Satake, M; Yamada, K | 1 |
| Li, H; Li, K; Wang, H; Zhang, Q; Zhang, Y; Zheng, J | 1 |
| Fu, J; Jin, Y; Li, X; Liang, X; Luo, Y; Zhang, J; Zhang, P; Zou, Q | 1 |
| Feng, W; Tang, Z; Wang, Q; Yang, Y | 1 |
| Cai, W; Chen, B; Geng, C; Jiang, L; Lu, H; Sun, J; Yang, B; Zhou, Y | 1 |
| Abdul Rahman, MB; Abdulmalek, E; Cordova, KE; Fakurazi, S; Kamal, NAMA | 1 |
| Chen, JY; Jiang, JL; Ma, T; Qi, WX; Xu, HP | 1 |
8 other study(ies) available for arginyl-glycyl-aspartic acid and gemcitabine
| Article | Year |
|---|---|
Suppression of pancreatic tumor growth in the liver by systemic administration of the TRAIL gene driven by the hTERT promoter.
Topics: Adenoviridae; Animals; Apoptosis Regulatory Proteins; Combined Modality Therapy; Deoxycytidine; DNA-Binding Proteins; Drug Synergism; Gemcitabine; Genetic Therapy; Humans; Liver; Liver Neoplasms; Membrane Glycoproteins; Mice; Mice, Nude; Oligopeptides; Pancreatic Neoplasms; Promoter Regions, Genetic; Telomerase; TNF-Related Apoptosis-Inducing Ligand; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 2005 |
Anticancer effects of gemcitabine are enhanced by co-administered iRGD peptide in murine pancreatic cancer models that overexpressed neuropilin-1.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Deoxycytidine; Disease Models, Animal; Drug Synergism; Female; Gemcitabine; Humans; Male; Mice; Middle Aged; Neuropilin-1; Oligopeptides; Pancreatic Neoplasms; Xenograft Model Antitumor Assays | 2014 |
A Novel Strategy to Improve the Therapeutic Efficacy of Gemcitabine for Non-Small Cell Lung Cancer by the Tumor-Penetrating Peptide iRGD.
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Deoxycytidine; Female; Gemcitabine; Humans; Mice; Mice, Inbred BALB C; Oligopeptides | 2015 |
Co-Delivery of Gemcitabine and Paclitaxel in cRGD-Modified Long Circulating Nanoparticles with Asymmetric Lipid Layers for Breast Cancer Treatment.
Topics: Animals; Antineoplastic Agents; Apoptosis; Biomarkers; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Deoxycytidine; Drug Carriers; Drug Compounding; Drug Delivery Systems; Gemcitabine; Lipids; Mice; Nanoparticles; Oligopeptides; Paclitaxel; Tissue Distribution | 2018 |
Gemcitabine-loaded RGD modified liposome for ovarian cancer: preparation, characterization and pharmacodynamic studies.
Topics: Animals; Antimetabolites, Antineoplastic; Cell Line, Tumor; Cell Survival; China; Deoxycytidine; Drug Delivery Systems; Drug Liberation; Female; Gemcitabine; Humans; Liposomes; Mice; Mice, Inbred BALB C; Nanoparticles; Oligopeptides; Ovarian Neoplasms; Particle Size; Rats | 2019 |
Encapsulation of gemcitabine in RGD-modified nanoliposomes improves breast cancer inhibitory activity.
Topics: Animals; Antimetabolites, Antineoplastic; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Deoxycytidine; Drug Carriers; Drug Compounding; Drug Delivery Systems; Drug Liberation; Drug Stability; Emulsions; Female; Gemcitabine; Humans; Liposomes; Male; Mice; Nanoparticles; Oligopeptides; Particle Size; Rats; Rats, Sprague-Dawley; Surface Properties; Xenograft Model Antitumor Assays | 2020 |
Surface peptide functionalization of zeolitic imidazolate framework-8 for autonomous homing and enhanced delivery of chemotherapeutic agent to lung tumor cells.
Topics: Antineoplastic Agents; Cell Line; Cell Survival; Deoxycytidine; Gemcitabine; Humans; Imidazoles; Lung Neoplasms; Metal-Organic Frameworks; Nanoparticles; Oligopeptides; Surface Properties; Zeolites | 2021 |
A Novel Delivery System of RGD-HSA Loaded GEM/CUR Nanoparticles for the Treatment of Pancreatic Cancer Therapy.
Topics: Animals; Cell Line, Tumor; Curcumin; Deoxycytidine; Drug Carriers; Gemcitabine; Humans; Mice; Nanoparticles; Oligopeptides; Pancreatic Neoplasms; Particle Size; Serum Albumin, Human | 2022 |